AstraZeneca to build $2b cancer drug manufacturing plant in Singapore

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 66%

Astrazeneca News

Health Health Latest News,Health Health Headlines

Singapore will soon be able to fully produce personalised cancer treatment locally. Pharmaceutical giant AstraZeneca intends to build a S$2-billion facility to manufacture innovative medicine used in cancer treatments. Construction will start by end-2024 and it should be operational by 2029.

This marks the first manufacturing investment in Singapore for the Anglo-Swedish company. While the location of the new site has not been announced, AstraZeneca said it will be the first end-to-end production site for such cancer treatment in the world.

This marks the first manufacturing investment in Singapore for the Anglo-Swedish company. While the location of the new site has not been announced, AstraZeneca said it will be the first end-to-end production site for such cancer treatment in the world.News Video ReportsWe know it's a hassle to switch browsers but we want your experience with CNA to be fast, secure and the best it can possibly be.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines